Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases
Online download statistics by month:
Online download statistics by month: September 2021 to July 2022
Abstract
Full
Pdf
Sep 2021
39
17
12
Oct 2021
260
4
0
Nov 2021
343
3
2
Dec 2021
234
1
0
Jan 2022
232
4
2
Feb 2022
147
1
1
Mar 2022
298
0
0
Apr 2022
236
0
0
May 2022
216
2
1
Jun 2022
239
9
3
Jul 2022
209
2
0
Total
2453
43
21
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF